Pharmacoepi and Health care Research Group within SIPBS, University of Strathclyde.
- Tweets521
- Following135
- Followers278
- Likes567
ALT Are you a professional in Scotland, interested / working in PROMs (including, but not exclusive to, cancer)? We are evaluating the Scottish Cancer PROMs Toolkit so that it can be improved. What will I need to do? If you choose to, you can: Complete an online questionnaire, and/or take part in an interview / focus group. You can opt in to this at the end of the questionnaire, or by emailing the researchers below. Do I have to take part? No. Taking part is your choice. You can say no or withdraw at any time. You do not need to be a healthcare professional or to have used the Toolkit to take part. Who can I talk to? Amanda Vettini (the researcher) [email protected] or Emma Dunlop (the study lead) [email protected]. Study closes 31/10. Advert includes a QR code to questionnaire: https://strathsci.qualtrics.com/jfe/form/SV_5vaYL8dqlVjIjm6
ALT This study is for people 18 + with Type 1 diabetes with/without sight loss, including any level of partial sight loss. Shaheena Fakir, a visiting researcher to University of Strathclyde from University of Waterloo, Canada, is exploring how people with Type 1 diabetes with/without sight loss use devices to monitor & manage diabetes medicines. This research can help future devices become more accessible, safe & usable by people with Type 1 diabetes with different needs related to vision/sight to monitor and manage their diabetes medicines. To take part, you must be: aged 18 or over, living with Type 1 diabetes & have any level of sight - from no sight loss to partial or full sight loss- & willing to share your experiences with medicines and devices used to manage and monitor your diabetes. Participation involves an online (Teams) or telephone interview which will last max 60 minutes. Please contact [email protected] / [email protected] for info.
ALT This study is for people 18 + with Type 1 diabetes with/without sight loss, including any level of partial sight loss. Shaheena Fakir, a visiting researcher to University of Strathclyde from University of Waterloo, Canada, is exploring how people with Type 1 diabetes with/without sight loss use devices to monitor & manage diabetes medicines. This research can help future devices become more accessible, safe & usable by people with Type 1 diabetes with different needs related to vision/sight to monitor and manage their diabetes medicines. To take part, you must be: aged 18 or over, living with Type 1 diabetes & have any level of sight - from no sight loss to partial or full sight loss- & willing to share your experiences with medicines and devices used to manage and monitor your diabetes. Participation involves an online (Teams) or telephone interview which will last max 60 minutes. Please contact [email protected] / [email protected] for info.
ALT A photo of PhD candidate Hanan with her academic supervisors and examiners following her PhD Viva. She is holding a balloon and a bunch of yellow flowers.
